Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients
Arunkumar Krishnan(West Virginia University), Tinsay A. Woreta(Johns Hopkins University), Esteban Mezey(Unknown), Laura Prichett(Johns Hopkins University), Ahyoung Kim(Johns Hopkins University), James P. Hamilton(Johns Hopkins University), Po‐Hung Chen(Johns Hopkins University), Xueting Tao(Johns Hopkins University), Saleh A. Alqahtani(Cornell University), James J. Potter(Johns Hopkins University), Alexandra T. Strauss(Johns Hopkins University)
Cited by 38
Related Papers
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving.
|Endocrinology|1993|1.5k
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
|Human Molecular Genetics|2003|337
Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis
|Hepatology|2014|224
A global research priority agenda to advance public health responses to fatty liver disease
|Journal of Hepatology|2023|132
Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol.
|Proceedings of the National Academy of Sciences|1994|112